Showing results (1781-1790 of 2,008) with videos related to

Sort By:
Pageof 201
Science (New York, N.Y.)|March 30, 2023
Base editing rescue of spinal muscular atrophy in cells and in miceMandana Arbab, Zaneta Matuszek, Kaitlyn M Kray, et al.
Cell|September 1, 2023
Phage-assisted evolution and protein engineering yield compact, efficient prime editorsJordan L Doman, Smriti Pandey, Monica E Neugebauer, et al.
British Journal of Pharmacology|December 17, 2013
Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivoN Fakhrudin, B Waltenberger, M Cabaravdic, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
A molecular glue approach to control the half-life of CRISPR-based technologiesVedagopuram Sreekanth, Max Jan, Kevin T Zhao, et al.
Nature Materials|May 20, 2020
Synthesis of mesoscale ordered two-dimensional π-conjugated polymers with semiconducting propertiesG Galeotti, F De Marchi, E Hamzehpoor, et al.
Nature Biotechnology|June 15, 2023
Adenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryosLiang Chen, Mengjia Hong, Changming Luan, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Small-molecule binding and sensing with a designed protein familyGyu Rie Lee, Samuel J Pellock, Christoffer Norn, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cellsB A Malcolm, R Liu, F Lahser, et al.
Zhonghua Yi Xue Za Zhi|December 12, 2018
[Clinical outcomes with beta-blockers in stable patients undergoing percutaneous coronary intervention with adequate left ventricular ejection function]Y Chen, Y Song, J J Xu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 22, 2016
[Chinese multicenter randomized trial of customized chemotherapy based on BRCA1 (breast cancer susceptibility gene 1)-RAP80 (receptor-associated protein 80) mRNA expression in advanced non-small cell lung cancer (NSCLC) patients]J Wei, X P Qian, Z Y Zou, et al.
Pageof 201